loading
Schlusskurs vom Vortag:
$6.66
Offen:
$6.68
24-Stunden-Volumen:
437.05K
Relative Volume:
0.16
Marktkapitalisierung:
$675.63M
Einnahmen:
$58.36M
Nettoeinkommen (Verlust:
$-25.72M
KGV:
-18.61
EPS:
-0.3641
Netto-Cashflow:
$-24.91M
1W Leistung:
-0.73%
1M Leistung:
+21.47%
6M Leistung:
+132.14%
1J Leistung:
+23.68%
1-Tages-Spanne:
Value
$6.575
$6.87
1-Wochen-Bereich:
Value
$6.39
$7.0844
52-Wochen-Spanne:
Value
$2.12
$7.55

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Firmenname
Aquestive Therapeutics Inc
Name
Telefon
908-941-1900
Name
Adresse
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Mitarbeiter
142
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
AQST's Discussions on Twitter

Vergleichen Sie AQST mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
AQST
Aquestive Therapeutics Inc
6.775 805.68M 58.36M -25.72M -24.91M -0.3641
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
142.84 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.41 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.2433 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.09 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
447.64 19.53B 3.08B 1.24B 1.07B 25.61

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Fortgesetzt Oppenheimer Outperform
2024-12-17 Eingeleitet Cantor Fitzgerald Overweight
2024-05-10 Eingeleitet Leerink Partners Outperform
2024-04-11 Eingeleitet Piper Sandler Overweight
2024-03-28 Eingeleitet Raymond James Outperform
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2019-04-22 Eingeleitet H.C. Wainwright Buy
2019-01-03 Eingeleitet Lake Street Buy
2018-08-20 Eingeleitet JMP Securities Mkt Outperform
2018-08-20 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten

pulisher
07:33 AM

Can Aquestive's Oral, Non-Device Epinephrine Film Capture A Share Of The Growing U.S. Market? - RTTNews

07:33 AM
pulisher
06:51 AM

Will Aquestive Therapeutics Inc. bounce back from current supportWeekly Profit Recap & Consistent Growth Equity Picks - newser.com

06:51 AM
pulisher
05:55 AM

Will Aquestive Therapeutics Inc. stock gain from strong economyJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com

05:55 AM
pulisher
05:41 AM

Can technical indicators confirm Aquestive Therapeutics Inc.’s reversalChart Signals & Stepwise Swing Trade Plans - newser.com

05:41 AM
pulisher
04:41 AM

Detecting support and resistance levels for Aquestive Therapeutics Inc.Earnings Miss & Community Supported Trade Ideas - newser.com

04:41 AM
pulisher
01:23 AM

Why Aquestive Therapeutics Inc. stock could outperform in 2025Weekly Stock Recap & Low Drawdown Investment Ideas - newser.com

01:23 AM
pulisher
01:09 AM

Why Aquestive Therapeutics Inc. stock is trending among retail tradersTrade Volume Report & Fast Momentum Stock Entry Tips - newser.com

01:09 AM
pulisher
12:53 PM

Real time alert setup for Aquestive Therapeutics Inc. performance2025 Biggest Moves & Safe Swing Trade Setups - newser.com

12:53 PM
pulisher
Oct 30, 2025

Risk vs reward if holding onto Aquestive Therapeutics Inc.2025 Volatility Report & Smart Money Movement Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Aquestive Therapeutics Inc. stock chart pattern explainedMarket Risk Report & Real-Time Market Trend Scan - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Using AI based signals to follow Aquestive Therapeutics Inc.2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Long term hold vs stop loss in Aquestive Therapeutics Inc.July 2025 Movers & Reliable Volume Spike Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What Wall Street predicts for Aquestive Therapeutics Inc. stock priceGDP Growth & Safe Entry Trade Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Top chart patterns to watch in Aquestive Therapeutics Inc.July 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Is Aquestive Therapeutics Inc. stock attractive for retirement portfoliosWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Will Aquestive Therapeutics Inc. stock benefit from AI adoptionCPI Data & Safe Swing Trade Setup Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Dividend Hike & High Accuracy Investment Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Why Aquestive Therapeutics Inc. stock attracts high net worth investors - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Aquestive Therapeutics to Report Third Quarter 2025 - GlobeNewswire

Oct 27, 2025
pulisher
Oct 27, 2025

Volatility clustering patterns for Aquestive Therapeutics Inc.July 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Aquestive Therapeutics (AQST) to Release Quarterly Earnings on Monday - MarketBeat

Oct 27, 2025

Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aquestive Therapeutics Inc-Aktie (AQST) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Jung Cassie
Chief Operating Officer
Oct 15 '25
Sale
7.01
67,575
473,701
240,771
Kraus Carl N
Chief Medical Officer
Oct 15 '25
Sale
7.00
20,272
141,904
282,475
Boyd Peter E.
See Remarks
Oct 15 '25
Sale
7.00
10,000
70,000
268,323
$46.91
price up icon 6.10%
drug_manufacturers_specialty_generic RDY
$13.31
price down icon 1.04%
$22.70
price up icon 0.55%
$10.39
price up icon 0.25%
$140.50
price up icon 1.73%
$448.78
price down icon 1.16%
Kapitalisierung:     |  Volumen (24h):